After ‘Puzzling’ Results For Antibody Drug, AC Immune’s Alzheimer’s Vaccine Shows Early Promise

A Blip Or A Breakthrough In Tau?

 
• By Andrew McConaghie
  
AC Immune
AC Immune has Alzheimers's collaborations in anti-tau and beta-amyloid modalities with companies such as Lilly, J&J and Roche. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D